Abstract:Gastrointestinal tumors are the most common cancers with the highest morbidity and mortality worldwide. Surgery accompanied by chemotherapy, radiotherapy and targeted therapy remains the first option for gastrointestinal tumors. However, poor specificity for tumor cells of these postoperative treatments often leads to severe side effects and poor prognosis. Tumor immunotherapy, including checkpoint blockade and tumor vaccines, has developed rapidly in recent years, showing good curative effects and minimal side effects in the treatment of gastrointestinal tumors. National Comprehensive Cancer Network guidelines recommend tumor immunotherapy as part of the treatment of gastrointestinal tumors. However, the heterogeneity of tumor cells, complicacy of the tumor microenvironment and poor tumor immunogenicity hamper the effectiveness of tumor immunotherapy. Hydrogels, defined as three-dimensional, hydrophilic, and water-insoluble polymeric networks, could significantly improve the overall response rate of immunotherapy due to their superior drug loading efficacy, controlled release and drug codelivery ability. In this article, we briefly describe the research progress made in recent years on hydrogel delivery systems in immunotherapy for gastrointestinal tumors and discuss the potential future application prospects and challenges to provide a reference for the clinical application of hydrogels in tumor immunotherapy.

Injectable Hydrogel As a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor Microenvironment

Application of injectable hydrogels in cancer immunotherapy

Locally Injectable Hydrogels for Tumor Immunotherapy

Injectable hydrogels as emerging drug-delivery platforms for tumor therapy

Engineered Bio‐Based Hydrogels for Cancer Immunotherapy

Smart Injectable Hydrogels For Cancer Immunotherapy

Injectable Hydrogels for Localized Cancer Therapy

Hydrogel systems for spatiotemporal controlled delivery of immunomodulators: engineering the tumor immune microenvironment for enhanced cancer immunotherapy

Injectable Zwitterionic Physical Hydrogel with Enhanced Chemodynamic Therapy and Tumor Microenvironment Remodeling Properties for Synergistic Anticancer Therapy

Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy

Advances in the Application of Injectable Thermosensitive Hydrogel Systems for Cancer Therapy

Polymer-based hydrogels with local drug release for cancer immunotherapy

Designing Hydrogels for Immunomodulation in Cancer Therapy and Regenerative Medicine

Progress in the application of hydrogels in immunotherapy of gastrointestinal tumors

Tumor Lysates-Constructed Hydrogel to Potentiate Tumor Immunotherapy

Biomacromolecular hydrogel scaffolds from microfluidics for cancer therapy: A review

Hydrogel-mediated Tumor T Cell Infiltration and Immune Evasion to Reinforce Cancer Immunotherapy.

An Injectable Hydrogel to Modulate T Cells for Cancer Immunotherapy

Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer

An engineered hydrogel with low-dose antitumor drugs enhances tumor immunotherapy through tumor interstitial wrap

Innovative hydrogel-based delivery systems for immunotherapy: A review of pre-clinical progress